about
sameAs
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guidelineMutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaGenome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseFrontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresNeologistic jargon aphasia and agraphia in primary progressive aphasiaWord-finding difficulty: a clinical analysis of the progressive aphasias.Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trialThe prevalence and causes of dementia in people under the age of 65 yearsMolecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P componentMolecular genetic characterisation of frontotemporal dementia on chromosome 3Amnesia, cerebral atrophy, and autoimmunityMorphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological reportPotassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisEarly-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein geneTransportin1: a marker of FTLD-FUSFamilial non-specific dementia maps to chromosome 3Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy seriesDeveloping an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkGenetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseThe diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseResearch criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseClinical and biomarker changes in dominantly inherited Alzheimer's disease.Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).Research priorities to reduce the global burden of dementia by 2025.Auditory hedonic phenotypes in dementia: A behavioural and neuroanatomical analysis.Receptive prosody in nonfluent primary progressive aphasias.Mapping the progression of progranulin-associated frontotemporal lobar degenerationCreation of an open-access, mutation-defined fibroblast resource for neurological disease research.Abnormal laughter-like vocalisations replacing speech in primary progressive aphasia.Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseasePreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.Compulsive versifying after treatment of transient epileptic amnesia.HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.Genetic variability in CLU and its association with Alzheimer's disease.Familial progressive supranuclear palsy.Microglial activation and amyloid deposition in mild cognitive impairment: a PET study
P50
Q22242395-7F25122B-8681-45E7-8801-C6C7A7C3698FQ24309521-0AF94728-B0C1-47E5-8F81-FFAD6FB27ACCQ24598142-71F9B82C-8B81-4B2B-A187-767124625BBBQ24612662-4EE64752-8523-4303-BAD4-C2236F969FA3Q24630410-39114AFA-35E3-4A3E-9323-6F89660BB0F6Q24642766-5A978035-5CAA-4E59-B0D2-970188DF7CCEQ24644914-8BBBA846-5C7D-4FCD-9408-669FE8D90CBFQ24653364-14E2A4DA-C10E-48D0-B2E3-AA2D376B6011Q24671745-563DECB8-A7FC-4E11-9D33-E1475AA77760Q27654862-7FD23AE8-59CF-478F-B4E3-7BF44546B89CQ28141390-AF987B19-E616-4C1D-AAAB-6FE75FB4C5A3Q28191502-97359D5A-142E-4F5F-AE4B-F4097E8E04D5Q28235976-02E45C87-C62D-4821-8AA7-8DF92D78A4C6Q28244864-497A84B6-9D4E-4395-B67F-B02121986D70Q28245149-2A074227-AD39-45F2-A25B-79785FD49291Q28245695-60882648-9877-44D3-A373-9667F65295A6Q28272020-A4625942-AB70-4DC5-AB4A-5255474575DFQ28603387-E3F2FE9F-0127-4657-BAD8-050CDAA88953Q28714253-A0554E1D-18E5-4A35-AFAC-FD6AE1F02DB7Q28748461-935B602B-F366-46FA-B2E8-356447445AFDQ29547554-DA0D88FC-D999-4B6C-A5C4-4FE1D827A889Q29614408-E535780E-0FF4-4638-B09E-7AC8271ACB4EQ29614879-AB47C33D-83A9-4C43-A3F3-37CDBFA1849EQ29619940-566008D7-F9A0-44F8-A5C2-5BDF879C51D6Q30244121-6F3EAD79-ADD7-48D7-9512-A4ABAC8C52CDQ30244419-17D50C22-CDF0-49E0-96B1-CB9FF747411AQ30374290-98FE7576-A519-4A36-BD2D-DC0FF093E146Q30469929-EA34B0FF-05D0-42EB-8DD0-D5BB529C3B1FQ30484077-F5389C1D-519F-487A-8355-40767700BC56Q30485675-AE0D44C1-20F3-4159-A5D4-F05CD3480CF6Q30487358-3D5DBC94-05A4-4D8D-AFB1-D396FF6C34CAQ30557788-45CC6957-2A78-4E28-9B2B-C0D7556C2B99Q30561855-D2909ACD-8110-41C6-9942-086A45CD7432Q33178131-032F8287-9E1F-4DCA-8D3C-B147D892147AQ33183411-969C0C99-2945-4C1A-8D32-513DF5FA8A55Q33462704-88C0F8AF-7B3D-4582-AE7C-8A05CBDA21E4Q33503386-D57EC923-1964-4330-A0AB-5614FC40AD20Q33538000-17443B97-D286-4F83-882F-4B6BD9A7956DQ33591114-011C2EF2-58BE-4269-819A-BF79DD4ED189Q33634089-8FC41E32-6237-4C00-B285-A38516F56A88
P50
description
researcher ORCID 0000-0001-8215-3120
@en
wetenschapper
@nl
name
Martin Rossor
@ast
Martin Rossor
@en
Martin Rossor
@es
Martin Rossor
@nl
type
label
Martin Rossor
@ast
Martin Rossor
@en
Martin Rossor
@es
Martin Rossor
@nl
altLabel
Martin N Rossor
@ast
Martin N Rossor
@en
Martin N Rossor
@nl
Martin N. Rossor
@en
Martin Rossor
@en
prefLabel
Martin Rossor
@ast
Martin Rossor
@en
Martin Rossor
@es
Martin Rossor
@nl
P106
P1153
7103182857
P21
P31
P496
0000-0001-8215-3120